Literature DB >> 12065371

The potentially coercive nature of some clinical research trial acronyms.

James P Orlowski1, James A Christensen.   

Abstract

STUDY
OBJECTIVES: To evaluate the potential coerciveness of clinical research trial (CRT) acronyms, and to make clinicians aware that some CRT acronyms may be coercive to research subjects by subliminally enticing or outwardly promising something that the CRT may not be able to deliver.
DESIGN: Analysis of CRT acronyms for pleasantness and meaningfulness as assessed by studies in the behavioral and social psychology literature.
RESULTS: Of 2,383 acronyms for CRTs analyzed, 155 acronyms (6.5%) were assessed as possibly, probably, or almost certainly coercive. On a Likert scale from 1 to 5 for pleasantness or meaningfulness, the acronyms identified as almost certainly coercive had a mean pleasantness score of 4.21 (range, 3.70 to 4.57), the acronyms identified as probably coercive had a mean score of 3.79 (range, 2.45 to 5.00), and the acronyms identified as possibly coercive had a mean score of 3.89 (range, 2.81 to 5.00).
CONCLUSIONS: A distraught or frightened patient with a life-threatening illness who is offered a research study with an acronym of CURE, HOPE, HELP, IMPROVED, LIFE, RESCUE, MIRACL (sic), SAVED, or ALIVE is possibly being coerced by the acronym. Institutional review boards (IRBs) and the medical research community would not tolerate a CRT entitled, "A Surefire Cure for Cancer." They should be no more tolerant of a CRT with an acronym listed above. It is time for researchers, sponsors, and IRBs to take a more responsible approach to potentially coercive CRT acronyms and discourage or prohibit their use.

Entities:  

Mesh:

Year:  2002        PMID: 12065371     DOI: 10.1378/chest.121.6.2023

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Acronymesis: the exploding misuse of acronyms.

Authors:  Herbert L Fred; Tsung O Cheng
Journal:  Tex Heart Inst J       Date:  2003

2.  Syndemics: A theory in search of data or data in search of a theory?

Authors:  Alexander C Tsai
Journal:  Soc Sci Med       Date:  2018-03-30       Impact factor: 4.634

Review 3.  Compliance in early-phase cancer clinical trials research.

Authors:  Razelle Kurzrock; David J Stewart
Journal:  Oncologist       Date:  2013-03-01

4.  Reporting ethics committee approval in public administration research.

Authors:  Sara R Jordan; Phillip W Gray
Journal:  Sci Eng Ethics       Date:  2013-04-12       Impact factor: 3.525

Review 5.  Persuasion and coercion: a critical review of philosophical and empirical approaches.

Authors:  Penny Powers
Journal:  HEC Forum       Date:  2007-06

6.  Novel participatory methods of involving patients in research: naming and branding a longitudinal cohort study, BRIGHTLIGHT.

Authors:  Rachel M Taylor; Jasjeet Mohain; Faith Gibson; Anita Solanki; Jeremy Whelan; Lorna A Fern
Journal:  BMC Med Res Methodol       Date:  2015-03-14       Impact factor: 4.615

Review 7.  SearCh for humourIstic and Extravagant acroNyms and Thoroughly Inappropriate names For Important Clinical trials (SCIENTIFIC): qualitative and quantitative systematic study.

Authors:  Anton Pottegård; Maija Bruun Haastrup; Tore Bjerregaard Stage; Morten Rix Hansen; Kasper Søltoft Larsen; Peter Martin Meegaard; Line Haugaard Vrdlovec Meegaard; Henrik Horneberg; Charlotte Gils; Dorthe Dideriksen; Lise Aagaard; Anna Birna Almarsdottir; Jesper Hallas; Per Damkier
Journal:  BMJ       Date:  2014-12-16

8.  The shell game: how institutional review boards shuffle words.

Authors:  Simon N Whitney
Journal:  J Transl Med       Date:  2014-08-14       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.